[PSTX] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[PSTX] Poseida Therapeutics, Inc.
Announcement Date
29-Sep-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 26.80%
YoY-
Quarter Report
PSTX's Result
PSTX's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -30,428 -28,784 -23,613 -20,954 -28,627 -13,334 -12,884 77.43%
Tax 802 1,312 1,439 1,679 1,522 1,471 6 2522.07%
NP -30,428 -28,784 -23,613 -20,954 -28,627 -13,334 -12,890 77.38%
Tax Rate - - - - - - - -
Total Cost 30,428 28,784 23,613 20,954 28,627 13,334 12,890 77.38%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.53 -0.50 -0.59 -0.53 -0.72 -0.34 -1.05 -36.63%
EPS Diluted -0.53 -0.50 -0.59 -0.53 -0.72 -0.34 -1.05 -36.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.